Form 4: Yield10 Bioscience VP Reports Stock Transactions

Lynne H. Brum, VP of Planning and Communications at Yield10 Bioscience, reports the withholding of shares for tax obligations and acquisition of shares through the company's 401(k) plan.

Summary

• On August 15, 2024, Lynne H. Brum, VP of Planning and Communications at Yield10 Bioscience, reported transactions involving the company's common stock.
• 731 shares were disposed of to cover withholding taxes upon the partial vesting of Restricted Stock Units (RSUs) granted on February 15, 2024, at a price of $1.5.
• Brum also acquired 2,056 shares through the Yield10 Bioscience, Inc. 401(k) Plan.
• Following these transactions, Brum directly owns 5,867 shares and indirectly owns 2,056 shares through the 401(k) plan.
• The share numbers reflect the 1:24 reverse stock split that occurred on May 2, 2024.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions. The disposal of shares to cover taxes is neutral, while the 401(k) acquisition is mildly positive.

Positives

• Acquisition of 2,056 shares through the 401(k) plan indicates confidence in the company's future.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider activity.

Key Dates

Keywords

Yield10 Bioscience, YTEN, Lynne H. Brum, Form 4, Stock Transaction, RSU, 401(k), Beneficial Ownership, Reverse Stock Split